Skip to main content
. 2023 Nov 29;11(12):1780. doi: 10.3390/vaccines11121780

Figure 2.

Figure 2

The GMCs for baseline anti-pneumococcal IgG concentrations of PPSV23-covered serotypes among age and agender groups. (a) The GMCs for baseline anti-pneumococcal IgG concentrations in the middle-aged and elderly groups. (b) The GMCs for baseline anti-pneumococcal IgG concentrations in the male and female groups. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (Mann–Whitney U test).